Anavex Life Sciences Corp (AVXL)
SG&A Expenses
$10.35M
TTM · Period ending: · USD
AVXL SG&A Expenses
Latest reported$10.35Mperiod ending
Latest reported$10.35Mperiod ending
AVXL TTM SG&A Expenses ($9.41K → $10.35M)
TTM SG&A Expenses
High-resolution chart · PNG
AVXL sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 10,353,000 | |
| 12,468,000 | |
| 12,797,000 | |
| 13,817,000 | |
| 13,048,000 | |
| 11,340,000 | |
| 11,614,000 | |
| 11,162,000 | |
| 10,972,553 | |
| 11,428,553 | |
| 11,416,553 | |
| 12,039,553 | |
| 13,350,508 | |
| 13,287,959 | |
| 13,320,117 | |
| 13,070,068 | |
| 12,046,543 | |
| 11,295,219 | |
| 10,613,806 | |
| 9,017,511 | |
| 7,541,483 | |
| 6,488,833 | |
| 5,975,230 | |
| 5,856,609 | |
| 6,088,966 | |
| 6,096,218 | |
| 6,437,327 | |
| 6,846,599 | |
| 6,692,825 | |
| 6,924,475 | |
| 6,352,674 | |
| 5,989,170 | |
| 5,868,683 | |
| 5,653,330 | |
| 5,279,894 | |
| 5,008,275 | |
| 5,891,129 | |
| 5,620,948 | |
| 5,594,575 | |
| 7,837,147 | |
| 8,813,476 | |
| 8,392,129 | |
| 7,753,681 | |
| 4,836,978 | |
| 1,912,063 | |
| 1,932,383 | |
| 2,384,205 | |
| 2,236,580 | |
| 3,309,916 | |
| 2,663,059 | |
| 1,886,595 | |
| 1,870,076 | |
| 1,029,383 | |
| 1,244,339 | |
| 1,482,375 | |
| 1,662,963 | |
| 1,767,234 | |
| 2,321,380 | |
| 3,172,121 | |
| 3,572,945 | |
| 3,813,336 | |
| 3,645,359 | |
| 3,131,763 | |
| 2,930,765 | |
| 2,787,993 | |
| 2,901,070 | |
| 2,640,398 | |
| 2,593,728 | |
| 3,463,991 | |
| 3,748,717 | |
| 3,743,743 | |
| 3,814,422 | |
| 2,463,101 | |
| 1,591,190 | |
| 1,298,344 | |
| 618,224 | |
| 375,160 | |
| 166,861 | |
| 28,281 | |
| 25,476 | |
| 19,746 | |
| 14,067 | |
| 9,407 | |
| 0 |